167213-40-3

Basic information

• Product Name: Propanoic acid, 2-[4-(2-bromoethyl)phenoxy]-2-methyl-, ethyl ester
• CAS NO: 167213-40-3
• Molecular Formula: C14H19BrO3
• Molecular Weight: 315.207
• Mol File: 167213-40-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Propanoic acid, 2-[4-(2-bromoethyl)phenoxy]-2-methyl-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 2-[4-(2-bromoethyl)phenoxy]-2-methyl-, ethyl ester(167213-40-3)
• EPA Substance Registry System: Propanoic acid, 2-[4-(2-bromoethyl)phenoxy]-2-methyl-, ethyl ester(167213-40-3)

Safety Data

• Hazardous Substances Data: 167213-40-3(Hazardous Substances Data)

Upstream product

• 167213-41-4 ethyl 2-[4-(2-hydroxyethyl)phenoxy]-2-methylpropanoate 
• 558-13-4 carbon tetrabromide 
• 108-95-2 phenol 
• 18672-04-3 ethyl 2-methyl-2-phenoxypropanoate 
• 62734-46-7 ethyl 2-[4-(bromoacetyl)phenoxy]-2-methylpropionate 

Downstream Products

• 1005791-57-0 ethyl 2-[4-(2-azidoethyl)phenoxy]-2-methylpropanate 
• 1005791-46-7 ethyl 2-{4-[2-(2-hydroxy-2-phenylethylamino)ethyl]phenoxy}-2-methylpropanoate 
• 247073-81-0 ethyl 2-[4-(2-{[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino}ethyl)phenoxy]-2-methylpropionate 

Relevant articles and documents

SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES

The present invention relates to polysubstituted imidazolone derivatives, to the pharmaceutical compositions comprising them and to the therapeutic uses thereof in the human and animal health fields. The present invention also relates to a process for preparing these derivatives.

2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same

The present invention provides novel 2-methylpropionic acid derivatives represented by the general formula: (wherein R1 represents a hydroxy group, a lower alkoxy group or an aralkyl group; R2 represents a hydroxy group, a lower alkyl group or a halogen atom; A represents an oxygen atom or an imino group; the carbon atom marked with (R) represents a carbon atom in R configuration; and the carbon atom marked with (S) represents a carbon atom in S configuration) and pharmaceutically acceptable salts thereof, which have excellent β3-adrenoceptor stimulating effects and are useful as agents for the prevention or treatment of obesity, hyperglycemia, the diseases caused by intestinal hypermotility, pollakiuria, urinary incontinence, depression, or the diseases caused by biliary calculi or hypermotility of biliary tract.